ALL CEO Thomas J. Wilson reports planned stock sales in Nov 2025

Rhea-AI Filing Summary

The Allstate Corporation (ALL) reported that its Chairman, President & CEO, Thomas J. Wilson, sold Allstate common stock in open-market transactions on 11/17/2025. He sold 15,370 shares at a weighted average price of $213.1159, 1,137 shares at $213.9619, and 300 shares at $214.7028, with actual prices in disclosed ranges for each trade. These sales were made under a Rule 10b5-1 trading plan adopted on June 27, 2025, which is a pre-arranged plan for systematic stock sales. Following the reported transactions, Wilson beneficially owned 161,619.491 Allstate shares directly, in addition to multiple indirect holdings through various GRATs, a 401(k) plan, and a remainder trust.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

WILSON THOMAS J

(Last) (First) (Middle)

C/O THE ALLSTATE CORPORATION

3100 SANDERS ROAD

(Street)

NORTHBROOK IL 60062-7154

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
ALLSTATE CORP [ ALL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chairman, President & CEO

3. Date of Earliest Transaction (Month/Day/Year)
11/17/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/17/2025		S		15,370	D	$213.1159(1)	163,056.491(2)	D
Common Stock	11/17/2025		S		1,137	D	$213.9619(3)	161,919.491(2)	D
Common Stock	11/17/2025		S		300	D	$214.7028(4)	161,619.491(2)	D
Common Stock								111,442	I	By 2023-B GRAT
Common Stock								65,321	I	By 2024-C GRAT
Common Stock								69,822	I	By 2025-A GRAT
Common Stock								7,643	I	By 401(k) Plan
Common Stock								273,954	I	By 2020 GRAT Remainder Trust
Common Stock								257,535	I	Remainder GRAT

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Reflects weighted average sale price for open-market sales transaction reported herein. Actual sale prices ranged from $212.57 to $213.56. The reporting person provided the issuer, and will provide any security holder of The Allstate Corporation or member of the SEC staff, full information regarding the number of shares sold at each separate price upon request.

2. The sale transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted on June 27, 2025.

3. Reflects weighted average sale price for open-market sales transaction reported herein. Actual sale prices ranged from $213.57 to 214.54. The reporting person provided the issuer, and will provide any security holder of The Allstate Corporation or member of the SEC staff, full information regarding the number of shares sold at each separate price upon request.

4. Reflects weighted average sale price for open-market sales transaction reported herein. Actual sale prices ranged from $214.64 to $214.94. The reporting person provided the issuer, and will provide any security holder of The Allstate Corporation or member of the SEC staff, full information regarding the number of shares sold at each separate price upon request.

	/s/ Thomas J. Wilson	11/19/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Allstate (ALL) report for its CEO?

On 11/17/2025, Allstate reported that Chairman, President & CEO Thomas J. Wilson sold Allstate common stock in several open-market transactions.

How many Allstate (ALL) shares did the CEO sell and at what prices?

Thomas J. Wilson sold 15,370 shares at a weighted average price of $213.1159, 1,137 shares at $213.9619, and 300 shares at $214.7028, each with disclosed price ranges.

Does the Allstate (ALL) CEO still hold shares after these sales?

Yes. After the reported transactions, Thomas J. Wilson beneficially owned 161,619.491 Allstate shares directly, plus additional indirect holdings in trusts and a 401(k) plan.

Were the Allstate (ALL) CEO’s stock sales made under a Rule 10b5-1 plan?

Yes. The sales reported were effected pursuant to a Rule 10b5-1 trading plan that was adopted on June 27, 2025.

What price ranges applied to the Allstate (ALL) stock sales reported?

The filing notes weighted average prices, with actual sale prices ranging from $212.57 to $213.56, $213.57 to $214.54, and $214.64 to $214.94 for the respective transactions.

What is Thomas J. Wilson’s relationship to Allstate (ALL)?

Thomas J. Wilson is reported as a Director and an Officer, serving as Chairman, President & CEO of The Allstate Corporation.